PeriPause

Suggested/Recommended/Usage/Directions

Directions: Take 1 capsule twice daily, or take 2 capsules right before bedtime.

Precautions re: All Other

Caution: For women only.

Precautions re: Pregnant or Nursing or Prescription Medications

Consult your physician prior to using this product if you are pregnant, nursing, taking medication, under the age of 18, have a medical condition or hormone- related cancer.

Precautions re: Children

Consult your physician prior to using this product if you are pregnant, nursing, taking medication, under the age of 18, have a medical condition or hormone- related cancer.

Precautions re: All Other

Use only as directed. Do not exceed recommended daily intake. Discontinue two weeks prior to surgery.

Storage

Store tightly closed in a cool, dry place.

Precautions re: Children

Keep out of reach of children.

FDA Disclaimer Statement

These statements have not been evaluated by the FDA. These products/ingredients are not intended to diagnose, treat, cure, or prevent any disease or condition

Formulation re: Other

Supports natural hormone balance Complete menopause relief may help with: Hot flashes Night sweats Mood swings Fatigue Insomnia Vaginal dryness Hormone free all natural

Formula re: Contains

Contains clinically proven and patented EstroG-100

FDA Statement of Identity

Dietary Supplement

General Statements: All Other Content

Changing hormones can wreak havoc on your mood, sleep and sex life. End the chaos with the clinically studied botanicals found in PeriPause.

Formula re: Contains

PeriPause with EstroG-100 is a patented, clinically studied herbal blend of extracts of Phlomis umbrosa, Cynanchum wilfordii and Angelica gigas.

Formula re: Type

PeriPause is intended for women suffering from the discomfort often associated with menopause and peri-menopause.

Formulation re: Other

EstrG-100 has demonstrated its ability to relieve: Hot flashes Night sweats Temporary sleeplessness Nervousness Difficulty in maintaining a positive outlook related to menopause.

General Statements: All Other Content

50% of women experienced improvement in at least one menopausal symptom within 7 days of use, with 75% experiencing improvement in at least one menopausal symptom within 14 days.